Record title
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study
Record identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e9995b5c481945709e7709fd5db97be9
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e9995b5c481945709e7709fd5db97be9
Share
CX-072 (pacmilimab), a Probody® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): an open-label dose-finding and first-in-human study
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Record Identifier
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Author / Creator
Thistlethwaite, Fiona
De Vries, Elisabeth G.E.
Eskens, Ferry A.L.M.
Uboha, Nataliya
Ott, Patrick A.
LoRusso, Patricia
Garcia-Corbacho, Javier
Boni, Valentina
Bendell, Johanna
Autio, Karen A.
Randhawa, Manreet
Durm, Greg
Gil-Martin, Marta
Stroh, Mark
Hannah, Alison L.
Arkenau, Hendrik-Tobias
Spira, Alexander
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e9995b5c481945709e7709fd5db97be9
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e9995b5c481945709e7709fd5db97be9
Other Identifiers
ISSN
E-ISSN
DOI